- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -
Drug Eluting Device Slows Vision Loss in Geographic Atrophy Brought on by Dry AMD
Posted By Irv Arons On April 11, 2011 @ 11:23 am In Consultant Articles,Industry News,Macular Degeneration,NeuroOphthalmology,New Technologies,Research,Retina | Comments Disabled
A new study, recently published in the Proceedings of the National Academy of Sciences (PNAS) shows that a potential treatment for the advanced stage of dry AMD, geographic atrophy (GA), can be used to slow vision loss in this blinding condition that affects more than a million people.
Neurotech Pharmaceuticals’ NT-501 drug eluting device can be placed in the vitreous of those suffering from GA and will deliver a neuroprotective agent, ciliary neurotrophic factor (CNTF), for up to a year and should result in preservation of vision.
NT-501 is not yet FDA approved, as further testing will be required before marketing can occur.
To read more about this development, please follow the link [1].
Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com
URL to article: http://eyedocnews.com/005237-drug-eluting-device-slows-vision-loss-in-geographic-atrophy-brought-on-by-dry-amd/
URLs in this post:
[1] link: http://tinyurl.com/AMDUpdate14
Click here to print.
Copyright © 2008 Eye Doc Talk. All rights reserved.